Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for prevention of radial artery spasm during coronary angiography and PCI
IRCT20201028049181N2Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in coronary arteriosclerosis, sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Incidence of radial artery spasm. Started Jun 2026; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20201028049181N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049181N2.